Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: The combined predictive power of the atherogenic index of plasma and serum glycated albumin for cardiovascular events in postmenopausal patients with acute coronary syndrome after percutaneous coronary intervention

Fig. 3

The event-free survival rate in AIP, GA, and combined groups for the individual adverse events. (A) Kaplan-Meier curves of AIP for cardiac death; (B) Kaplan-Meier curves of GA for cardiac death; (C) Kaplan-Meier curves of AIP + GA for cardiac death; (D) Kaplan-Meier curves of AIP for nonfatal MI; (E) Kaplan-Meier curves of GA for nonfatal MI; (F) Kaplan-Meier curves of AIP + GA for nonfatal MI; (G) Kaplan-Meier curves of AIP for nonfatal stroke; (H) Kaplan-Meier curves of GA for nonfatal stroke; (I) Kaplan-Meier curves of AIP + GA for nonfatal stroke. MI, myocardial infarction; AIP, atherogenic index of plasma; GA, glycated albumin; AIP-L + GA-L, lower AIP level + lower GA level; AIP-H + GA-L, higher AIP level + lower GA level; AIP-L + GA-H, lower AIP level + higher GA level; AIP-H + GA-H, higher AIP level + higher GA level

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X